The Rise of Personalised Medicine in Clinical Trials
Growing Trends in using SCEDs to Test Medical Devices
Decentralised & Remote N of 1 Trials Gain Momentum
FDA Rare Disease Innovation Hub: Impact on Industry and Patients
3 Key Insights from the 2024 MTPConnect Clinical Trials Report
N-of-1 Hub Declared a Finalist of the 2024 Australian Women’s Small Business Champion Awards
ARCS 2024 Conference Recap
Harnessing Single Case Experimental Design for Evidence-Based Complementary Medicine
FDA establishes Center for Clinical Trial Innovation
Medical Cannabis and Chronic Pain: Why N of 1 Trials May Offer a Better Solution
Master the Vocabulary: A Single-Case Design Terminology Guide
N of 1 Trials for ADHD in FASD: Collaboration with Monash Health
Advancing Rare Disease Research: N of 1 Trial Webinar Recap
Single-Case Design to test CBT for Chronic Whiplash: Collaboration with SDU
N-of-1 Hub and USC conduct N of 1 trials in Phenylketonuria
The Value of Single-Case Designs for Assessing Digital Health Data